StockData
CorMedix Inc. logo

CorMedix Inc. (CRMD) stock

CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.50−0.17 (-3.64%)

Close on Nov 18, 2026Market cap $350.75MP/E –Yield –

CorMedix market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

CorMedix's market cap was $411.64M on Nov 11, 2026, against $768.60M a year earlier. Over the last 5 years it ranged from $116.33M to $1.11B, with a median of $288.70M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$411.64M-54.8%
2025Dec 31, 2025$911.20M+94.3%
2024Dec 31, 2024$468.89M+127.5%
2023Dec 29, 2023$206.09M+18.5%
2022Dec 30, 2022$173.90M+0.3%
2021Dec 31, 2021$173.29M-25.6%
2020Dec 31, 2020$232.92M+24.7%
2019Dec 31, 2019$186.74M-70.7%
2018Dec 31, 2018$637.43M+311.4%
2017Dec 29, 2017$154.95M-49.9%
2016Dec 30, 2016$309.10M-13.9%
2015Dec 31, 2015$359.07M+68.4%
2014Dec 31, 2014$213.21M+115.5%
2013Dec 31, 2013$98.95M+140.9%
2012Dec 31, 2012$41.07M+157.1%
2011Dec 30, 2011$15.97M–

More CorMedix figures

See a number that looks wrong?